Venus Medtech (Hangzhou) (HKSE:02500) Pre-Tax Income : HK$-804.3 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Venus Medtech (Hangzhou)'s pretax income for the six months ended in Dec. 2023 was HK$-399.2 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-804.3 Mil. Venus Medtech (Hangzhou)'s pretax margin was -154.82%.

During the past 7 years, Venus Medtech (Hangzhou)'s highest Pretax Margin was -67.32%. The lowest was -866.81%. And the median was -163.56%.

Venus Medtech (Hangzhou) Pre-Tax Income Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) Pre-Tax Income Chart

Venus Medtech (Hangzhou) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-424.56

-220.30

-462.30

-1,291.31

-804.30

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial							-318.78	-288.84	-1,016.14	-405.07	-399.23

Competitive Comparison of Venus Medtech (Hangzhou)'s Pre-Tax Income

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Medtech (Hangzhou)'s Pre-Tax Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s Pre-Tax Income falls into.

Venus Medtech (Hangzhou) Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Venus Medtech (Hangzhou)'s Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-624.634	+	0	+	-68.597	+	37.688	+	-148.756
	=	-804.3

Venus Medtech (Hangzhou)'s Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-264.486	+	0	+	-34.488	+	0	+	-100.256
	=	-399.2

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-804.3 Mil.

Venus Medtech (Hangzhou) (HKSE:02500) Pre-Tax Income Explanation

Venus Medtech (Hangzhou)'s Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-399.23	/	257.873
	=	-154.82%

During the past 7 years, Venus Medtech (Hangzhou)'s highest Pretax Margin was -67.32%. The lowest was -866.81%. And the median was -163.56%.

Venus Medtech (Hangzhou) Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) (HKSE:02500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

VMTHF:USA

Address

No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051

Website

https://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.

Executives

Zeng Min Frank	2201 Interest of corporation controlled by you
Zi Zhenjun	2201 Interest of corporation controlled by you
Ming Zhi Investments (bvi) Limited	2101 Beneficial owner
Ming Zhi Investments Limited	2201 Interest of corporation controlled by you
Qiming Venture Partners Iii, L.p.	2201 Interest of corporation controlled by you
Qiming Corporate Gp Iii, Ltd.	2201 Interest of corporation controlled by you
Qiming Gp Iii, L.p.	2201 Interest of corporation controlled by you
Dcp Capital Partners, L.p.	2201 Interest of corporation controlled by you
Dcp General Partner, Ltd	2201 Interest of corporation controlled by you
Dcp, Ltd.	2201 Interest of corporation controlled by you
Liu Haifeng David	2201 Interest of corporation controlled by you
Muheng Capital Partners (hong Kong) Limited	2101 Beneficial owner
Red Giant Limited	2201 Interest of corporation controlled by you
Wolhardt Julian Juul	2201 Interest of corporation controlled by you
Horizon Binjiang Llc	2101 Beneficial owner

Venus Medtech (Hangzhou) (HKSE:02500) Headlines

No Headlines